BRANFORD, Conn., Dec. 16, 2025 /PRNewswire/ — RNAConnect, a life science company providing next generation tools to the RNA community, today announced the commercialBRANFORD, Conn., Dec. 16, 2025 /PRNewswire/ — RNAConnect, a life science company providing next generation tools to the RNA community, today announced the commercial

RNAConnect Launches the UltraMarathonRT® Direct RNA‑Seq Kit to Advance Nanopore-based Native RNA Sequencing

BRANFORD, Conn., Dec. 16, 2025 /PRNewswire/ — RNAConnect, a life science company providing next generation tools to the RNA community, today announced the commercial availability of the UltraMarathonRT® Direct RNA‑Seq (uMRT DRS) Kit, a native‑RNA library preparation solution for Oxford Nanopore Technologies® direct RNA sequencing (SQK-RNA004). The kit enables the detection of more genes, more isoforms, and longer transcripts than existing protocols. It employs a gentle 30 °C reverse‑transcription (RT) stabilization step and ultra‑processive enzyme performance to preserve RNA integrity, expand long‑transcript representation, and maintain endogenous RNA modification signals in ONT direct workflow.

Direct RNA-Seq requires an initial reverse transcription step to smooth out secondary structures and stabilize the RNA which is then pulled directly through the nanopore and read. Directly reading the RNA strand in this way enables strand‑specific, isoform‑resolved measurements alongside base‑modification information. The UltraMarathonRT Direct RNA‑Seq Kit streamlines this workflow with optimized reagents for current ONT RNA004 chemistry and a low‑temperature RT step that ensures more of each RNA sample gets sequenced.

Performance Highlights of the UltraMarathonRT Direct RNA-Seq Kit:
Compared to the existing recommended protocol, this kit’s novel chemistry and lower RT temperature (30°C) result in:

  • 25-50% higher cDNA yield
  • 5-10% longer read lengths, with very large differences in transcripts >2kb
  • 1-2% more genes detected
  • 15-20% more novel transcripts (NIC & NNIC) detected
  • 25-30% more intron retention events detected
  • Equivalent mapping rates & Q scores

“We took a hard look at existing direct RNA-seq protocols and saw places where our company’s deep knowledge of RNA combined with the unique properties of UltraMarathonRT could boost the output of long RNA reads,” said Dr. Jason Underwood, VP of Technology Development at RNAConnect. “RNAConnect is excited to unveil this easy-to-use kit and workflow to enable new discoveries from our vibrant RNA science community.”

“Long-read sequencing technologies have the amazing ability to access the full span of transcripts that can be kilobases or more in length,” added Dr. Paul Boutz, Assistant Professor at the University of Rochester School of Medicine and Dentistry, who was a beta-tester of the uMRT DRS Kit. “Unfortunately, most reverse transcriptases don’t. This was really hampering our ability to see the full spectrum of alternative splicing happening in transcripts, so discovering UltraMarathonRT has been a game changer. The new uMRT DRS Kit seamlessly integrates into the ONT direct RNA sequencing protocol and gives us fantastic results. We will definitely use it for our direct RNA sequencing moving forward.”

Availability:
The UltraMarathonRT Direct RNA‑Seq Kit is available immediately through RNAConnect and authorized distributors. For specifications, chemistry compatibility, and workflow guidance, please contact RNAConnect or visit the website.

About RNAConnect:
RNAConnect is a life science tools company dedicated to innovating RNA analysis solutions that advance research in genomics, transcriptomics, and molecular diagnostics. With a commitment to empowering scientists with sensitive, accurate, and reliable tools, RNAConnect’s products enable discoveries across rare diseases, immunology, oncology, neurobiology, and beyond.

Media Contact:
Andrew Bond, PhD — Chief Commercial Officer
Tel: +1‑475-338-2120
Email: [email protected]

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/rnaconnect-launches-the-ultramarathonrt-direct-rnaseq-kit-to-advance-nanopore-based-native-rna-sequencing-302642890.html

SOURCE RNAConnect

Piyasa Fırsatı
Cyberlife Logosu
Cyberlife Fiyatı(LIFE)
$0.0455
$0.0455$0.0455
-9.18%
USD
Cyberlife (LIFE) Canlı Fiyat Grafiği
Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen [email protected] ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

Japan-Based Bitcoin Treasury Company Metaplanet Completes $1.4 Billion IPO! Will It Buy Bitcoin? Here Are the Details

Japan-Based Bitcoin Treasury Company Metaplanet Completes $1.4 Billion IPO! Will It Buy Bitcoin? Here Are the Details

The post Japan-Based Bitcoin Treasury Company Metaplanet Completes $1.4 Billion IPO! Will It Buy Bitcoin? Here Are the Details appeared on BitcoinEthereumNews.com. Japan-based Bitcoin treasury company Metaplanet announced today that it has successfully completed its public offering process. Metaplanet Grows Bitcoin Treasury with $1.4 Billion IPO The company’s CEO, Simon Gerovich, stated in a post on the X platform that a large number of institutional investors participated in the process. Among the investors, mutual funds, sovereign wealth funds, and hedge funds were notable. According to Gerovich, approximately 100 institutional investors participated in roadshows held prior to the IPO. Ultimately, over 70 investors participated in Metaplanet’s capital raising. Previously disclosed information indicated that the company had raised approximately $1.4 billion through the IPO. This funding will accelerate Metaplanet’s growth plans and, in particular, allow the company to increase its balance sheet Bitcoin holdings. Gerovich emphasized that this step will propel Metaplanet to its next stage of development and strengthen the company’s global Bitcoin strategy. Metaplanet has recently become one of the leading companies in Japan in promoting digital asset adoption. The company has previously stated that it views Bitcoin as a long-term store of value. This large-scale IPO is considered a significant step in not only strengthening Metaplanet’s capital but also consolidating Japan’s role in the global crypto finance market. *This is not investment advice. Follow our Telegram and Twitter account now for exclusive news, analytics and on-chain data! Source: https://en.bitcoinsistemi.com/japan-based-bitcoin-treasury-company-metaplanet-completes-1-4-billion-ipo-will-it-buy-bitcoin-here-are-the-details/
Paylaş
BitcoinEthereumNews2025/09/18 08:42
CME Group to Launch Solana and XRP Futures Options

CME Group to Launch Solana and XRP Futures Options

The post CME Group to Launch Solana and XRP Futures Options appeared on BitcoinEthereumNews.com. An announcement was made by CME Group, the largest derivatives exchanger worldwide, revealed that it would introduce options for Solana and XRP futures. It is the latest addition to CME crypto derivatives as institutions and retail investors increase their demand for Solana and XRP. CME Expands Crypto Offerings With Solana and XRP Options Launch According to a press release, the launch is scheduled for October 13, 2025, pending regulatory approval. The new products will allow traders to access options on Solana, Micro Solana, XRP, and Micro XRP futures. Expiries will be offered on business days on a monthly, and quarterly basis to provide more flexibility to market players. CME Group said the contracts are designed to meet demand from institutions, hedge funds, and active retail traders. According to Giovanni Vicioso, the launch reflects high liquidity in Solana and XRP futures. Vicioso is the Global Head of Cryptocurrency Products for the CME Group. He noted that the new contracts will provide additional tools for risk management and exposure strategies. Recently, CME XRP futures registered record open interest amid ETF approval optimism, reinforcing confidence in contract demand. Cumberland, one of the leading liquidity providers, welcomed the development and said it highlights the shift beyond Bitcoin and Ethereum. FalconX, another trading firm, added that rising digital asset treasuries are increasing the need for hedging tools on alternative tokens like Solana and XRP. High Record Trading Volumes Demand Solana and XRP Futures Solana futures and XRP continue to gain popularity since their launch earlier this year. According to CME official records, many have bought and sold more than 540,000 Solana futures contracts since March. A value that amounts to over $22 billion dollars. Solana contracts hit a record 9,000 contracts in August, worth $437 million. Open interest also set a record at 12,500 contracts.…
Paylaş
BitcoinEthereumNews2025/09/18 01:39
Why the Testing Method Developers Prefer Is Rarely Ever the One That Finds the Most Bugs

Why the Testing Method Developers Prefer Is Rarely Ever the One That Finds the Most Bugs

A replicated controlled study confirms that developers’ perceptions, preferences, and opinions about software testing techniques do not reliably predict actual
Paylaş
Hackernoon2025/12/18 05:00